Extended-Release Calcifediol Normalized 1,25-Dihydroxyvitamin D and Prevented Progression of Secondary Hyperparathyroidism in Hemodialysis Patients in a Pilot Randomized Clinical Trial.
Saved in:
| Title: | Extended-Release Calcifediol Normalized 1,25-Dihydroxyvitamin D and Prevented Progression of Secondary Hyperparathyroidism in Hemodialysis Patients in a Pilot Randomized Clinical Trial. |
|---|---|
| Authors: | Bishop CW; OPKO Health, Miami, Florida, USA, cbishop@opko.com., Ashfaq A; OPKO Health, Miami, Florida, USA., Choe J; OPKO Health, Miami, Florida, USA., Strugnell SA; OPKO Health, Miami, Florida, USA., Johnson LL; Next Generation Clinical Research, Fitchburg, Wisconsin, USA., Norris KC; David Geffen School of Medicine, UCLA, Los Angeles, California, USA., Sprague SM; NorthShore University Health System-University of Chicago, Pritzker School of Medicine, Evanston, Illinois, USA. |
| Source: | American journal of nephrology [Am J Nephrol] 2026; Vol. 57 (1), pp. 109-119. Date of Electronic Publication: 2025 Jun 04. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Multicenter Study |
| Journal Info: | Publisher: Karger Country of Publication: Switzerland NLM ID: 8109361 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1421-9670 (Electronic) Linking ISSN: 02508095 NLM ISO Abbreviation: Am J Nephrol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1421-9670 |
|---|---|
| DOI: | 10.1159/000546615 |
